Lakefront Biotherapeutics News and Activities

Presence

Galapagos is a biotechnology company that develops and delivers medicines and cell therapies. Its products and research services support patients, healthcare providers, and pharmaceutical partners in immunology, oncology, and other serious diseases.

Lakefront Biotherapeutics products and services overview:

Cell therapies
Drug discovery
Clinical development
Immunology medicines
Oncology treatments
Research partnerships

Revenue: ~$300 million

Employees: 700

Headquarters: Mechelen, Belgium

Lakefront Biotherapeutics is one of the...

Lakefront Biotherapeutics is a company listed under the stock ticker GLPG (BE).

Executives

View the org chart displaying its 21 main executives

Most searched biographies at Lakefront Biotherapeutics

Popular executive movements at Lakefront Biotherapeutics

Guy Peeters, Senior Vice President, Finance, has left the company (posted on April 29 2026).
Gino Santini will join the company as Chairman of the Board on Apr. 28, 2026 (posted on April 3 2026).
Jérôme Contamine, Chairman of the Board, will leave the company on Apr. 28, 2026 (posted on March 30 2026).

Click here to view some more movements at Lakefront Biotherapeutics

Create your alert
to follow the executive moves at Lakefront Biotherapeutics.